Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
494.30%
Grew
—
—
Grew
—
1 Year
Score—
Net Growth494.30%
Net TrendGrew
Net Income Consistency—
Rev Growth—
Rev TrendGrew
Revenue Consistency—
5 Years
4.6
8x
40%
—
-26.20%
20%
—
5 Years
Score4.6
Net Growth8x
Net Trend40%
Net Income Consistency—
Rev Growth-26.20%
Rev Trend20%
Revenue Consistency—
Oramed Pharmaceuticals Inc fundamental performance
Between 2020 and 2025, revenue declined from $ 2M to $ 2M and net income went from -$ 11M to $ 75M. Revenue increased in 1 of those 5 years; net income in 2.
Oramed Pharmaceuticals Inc currently holds a 5-year HDB Score of 4.6 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 4.27 | — |
1 Year2025-08-12 | $ 1.96 | 118.11% |
5 Years2021-08-12 | $ 19.34 | -77.93% |
10 Years2016-08-12 | $ 7.27 | -41.28% |
20 Years2006-08-10 | $ 10.74 | -60.24% |
All Time2006-04-21 | $ 11.19 | -61.83% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | 20 Years2006-08-10 | All Time2006-04-21 |
|---|---|---|---|---|---|---|
| Price | $ 4.27 | $ 1.96 | $ 19.34 | $ 7.27 | $ 10.74 | $ 11.19 |
| Return | — | 118.11% | -77.93% | -41.28% | -60.24% | -61.83% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2025 | $ 2M | $ 75M | $ 51M |
| 2024 | $ 0.00 | -$ 19M | $ 141M |
| 2023 | $ 1M | $ 5M | $ 162M |
| 2022 | $ 2M | -$ 37M | $ 155M |
| 2021 | $ 2M | -$ 22M | $ 94M |
| 2020 | $ 2M | -$ 11M | $ 39M |
| 2019 | $ 2M | -$ 14M | $ 32M |
| 2018 | $ 2M | -$ 12M | $ 30M |
| 2017 | $ 2M | -$ 10M | $ 20M |
| 2016 | $ 641K | -$ 10M | $ 31M |
| 2015 | -$ 7M | $ 17M | |
| 2014 | -$ 5M | $ 21M | |
| 2013 | -$ 4M | $ 8M | |
| 2012 | $ 184.25K | -$ 3M | $ 4M |
| 2011 | $ 197.41K | -$ 1M | $ 1M |
| 2010 | -$ 2M | $ 1M | |
| 2009 | -$ 2M | $ 2M | |
| 2008 | -$ 2M | $ 4M | |
| 2007 | -$ 3M | $ 1M | |
| IPO2006 | -$ 414.58K | $ 176.19K |
Explore beyond ORMP
You're looking at Oramed Pharmaceuticals Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
